IQ U.S. Mid Cap R&D Leaders ETF
MRND
MRND was delisted on the 12th of December, 2023.
2 hedge funds and large institutions have $200K invested in IQ U.S. Mid Cap R&D Leaders ETF in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 2 → 2 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
98% less capital invested
Capital invested by funds: $9.62M → $200K (-$9.42M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$11K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MSL
Mackay Shields LLC
New York
|
-$4.81M |
MRND Hedge Fund Activity: Q2 2022 in Review
2 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in IQ U.S. Mid Cap R&D Leaders ETF (MRND) for Q2 2022, worth a combined $200K — down 98% from $9.62M a quarter earlier.
Fund positioning in MRND was balanced in Q2 2022: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $11K. The largest seller was Mackay Shields LLC, exiting entirely with an estimated $4.81M sold.
- 2 institutional investors held IQ U.S. Mid Cap R&D Leaders ETF (MRND) as of Q2 2022, unchanged from Q1 2022.
- Funds reported $200K of IQ U.S. Mid Cap R&D Leaders ETF stock for Q2 2022, down 98% quarter-over-quarter.
- 1 fund opened new IQ U.S. Mid Cap R&D Leaders ETF positions in Q2 2022 and 1 closed out, a net change of 0 holders.
- The largest IQ U.S. Mid Cap R&D Leaders ETF buyer in Q2 2022 was UBS Group, an estimated $11K added.
- The largest IQ U.S. Mid Cap R&D Leaders ETF seller in Q2 2022 was Mackay Shields LLC, an estimated $4.81M sold.
Based on aggregated 13F filings for Q2 2022.